-
Eye On the Cure Research News
Encouraging Early Report for Three Patients in LCA1-GUCY2D Gene Therapy Clinical Trial
-
Beacon Stories
-
Eye On the Cure Research News
Foundation Invests $5.5 Million in Seven New Translational Research Projects
-
Eye On the Cure Research News
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial
-
Eye On the Cure Research News
ProQR’s RNA Therapy for USH2A Performs Well in Phase 1/2 Clinical Trial

Our Track Record
The Foundation is committed to finding treatments and cures for people affected by blinding retinal diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$816M dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
82 grants awarded
in 2020 – over 90 investigators, 67 institutions
Learn more
The Foundation in the News
Encouraging Early Report for Three Patients in LCA1-GUCY2D Gene Therapy Clinical Trial
-
Apr 12, 2021 Beacon Stories
-
Apr 9, 2021 Eye On the Cure Research News
Foundation Invests $5.5 Million in Seven New Translational Research Projects
-
Mar 30, 2021 Eye On the Cure Research News
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial

Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now